PDF herunterladen
CC BY-NC-ND 4.0 · World J Nucl Med 2012; 11(01): 30-32
DOI: 10.4103/1450-1147.98745
Case Report

Post-treatment Assessment of Glioblastoma Multiforme: Imaging with Fluorodeoxyglucose, Sestamibi, and Choline

Chjoong Howe Tan
Department of Diagnostic Radiology, Khoo Teck Purt Hospital
,
Eik Hock Tan
1   Department of Nuclear Medicine and PET, Singapore General Hospital, Singapore
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
  als PDF herunterladen Lizenzen und Reprints

Glioblastoma multiforme (GBM) is the most common primary brain tumor in adults, and is generally of poor prognosis. The post-treatment assessment of GBMs is a known diagnostic issue, with problems in the differentiation of viable remnant tumor and post-treatment inflammatory changes. We present a case where various molecular tracers (fluorodeoxyglucose, choline, and methoxyisobutylisonitrile) were used in the post-treatment assessment of a patient with histologically proven GBM.

Keywords

Choline - fluorodeoxyglucose - glioblastoma multiforme - molecular imaging - sestamibi


Publikationsverlauf

Artikel online veröffentlicht:
21. Mai 2022

© 2012. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India